These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3696353)

  • 1. Atherogenesis and hypertension.
    Block LH
    Nephron; 1987; 47 Suppl 1():68-70. PubMed ID: 3696353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors, endothelial cell turnover and lipid transport in atherogenesis.
    Lin SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):309-16. PubMed ID: 9037845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells.
    Mori S; Ito H; Yamamoto K
    Tohoku J Exp Med; 1988 Apr; 154(4):329-33. PubMed ID: 3188001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension.
    Bühler FR; Tkachuk VA; Hahn AW; Resink TJ
    J Hypertens Suppl; 1991 Dec; 9(6):S28-36. PubMed ID: 1818968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects on aortic enzyme activities in spontaneously hypertensive rats.
    Tomita T; Shirasaki Y; Takiguchi Y; Ozaki Y; Hayashi E
    Atherosclerosis; 1980 Nov; 37(3):409-22. PubMed ID: 6257251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiatherosclerotic effects of calcium antagonists.
    Paoletti R; Bernini F; Corsini A; Soma MR
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S6-10. PubMed ID: 8852538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological basis for use of calcium channel antagonists in hypertension.
    Scriabine A; Kazda S; Garthoff B; Nickerson PA
    Angiology; 1988 Jan; 39(1 Pt 2):94-9. PubMed ID: 2449099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender dichotomy in reactivity to the vasoactive oxidant hydrogen peroxide in spontaneously hypertensive rats.
    Packer CS; Pelaez NJ; Johnson TC
    J Gend Specif Med; 2002; 5(3):17-23. PubMed ID: 12078058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and blood pressure related changes in cholesterol esterase activity and cholesterol content in aortas of stroke prone spontaneously hypertensive rats, spontaneously hypertensive rats and normotensive Wistar Kyoto rats.
    Tomita T; Shirasaki Y; Yamada K; Endo T; Hayashi E
    Paroi Arterielle; 1980; 6(1):19-25. PubMed ID: 7422353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinaemia accelerates accumulation of cholesterol ester in aorta of rats with transplanted pancreas.
    Abe H; Bandai A; Makuuchi M; Idezuki Y; Nozawa M; Oka T; Osuga J; Watanabe Y; Inaba T; Yamada N
    Diabetologia; 1996 Nov; 39(11):1276-83. PubMed ID: 8932992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism.
    Block LH; Knorr M; Vogt E; Locher R; Vetter W; Groscurth P; Qiao BY; Pometta D; James R; Regenass M
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):885-9. PubMed ID: 2829208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of low-density lipoprotein in the pathogenesis of atherosclerosis].
    Zák A; Rublicová J; Skorepa J
    Cas Lek Cesk; 1978 Oct; 117(42):1305-10. PubMed ID: 214233
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium antagonists and atherosclerosis.
    Schachter M
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S9-15. PubMed ID: 9488190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats.
    Aoki K; Kawaguchi Y; Sato K; Kondo S; Yamamoto M
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S298-302. PubMed ID: 6184557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of cholesterol, lipoproteins and atherosclerosis.
    Havel RJ
    Clin Exp Hypertens A; 1989; 11(5-6):887-900. PubMed ID: 2676261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertensive arteriopathy and atherogenesis: cellular and molecular interactions].
    Hadjiisky P; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1986 Nov; 79(12):1816-23. PubMed ID: 3105495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis, cell motility, calcium, and calcium-channel blockers.
    Block LH; Bühler FR
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S1-3. PubMed ID: 1377297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial smooth muscle contractions in spontaneously hypertensive rats on a high-calcium diet.
    Pörsti I
    J Hypertens; 1992 Mar; 10(3):255-63. PubMed ID: 1315823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combination of angiotensin receptor blocker and calcium channel blocker on ox-LDL levels and cardiovascular dysfunction in Dahl rats.
    Takayama M; Arakawa E; Yao K; Ina Y; Sato H; Hasegawa K; Kohno H; Ohno T
    Pharmacology; 2006; 77(4):179-87. PubMed ID: 16864986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.